About
Karleen M. Oberton was Chief Financial Officer of Hologic, Inc., a global medical technology company, from August 2018 to May 2026.
She brings to the AMETEK Board deep financial advisory, audit and SEC reporting experience as well as extensive global leadership experience at a public company. She has served as an AMETEK director since February 2021 and is a member of the Audit Committee, where she is designated an audit committee financial expert.
Roles
Ametek Inc.
Director · Current role
2021–present
Hologic, Inc.
Chief Financial Officer · Joined Hologic in 2006 as Vice President and Corporate Controller; named Corporate Vice President and Chief Accounting Officer in 2014, then elected CFO in 2018. Was an active Certified Public Accountant for more than 18 years.
August 2018 – May 2026
Hologic, Inc.
Corporate Vice President and Chief Accounting Officer
2014 – 2018
Hologic, Inc.
Vice President and Corporate Controller
2006 – 2014
ImmunoGen
Senior Corporate Controller · A biotechnology company developing targeted anticancer therapeutics; earlier held leadership positions at Ernst & Young and Arthur Andersen.
—
Director Compensation
FY 2025
Fees earned or paid in cash
$112,500